Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
The Changping District Joint Innovative Fund is a government-backed investment vehicle based in Beijing, China, specifically focused on fostering the growth of the life sciences and healthcare sectors within the Changping District. Operating primarily out of the Zhongguancun Life Science Park, the fund provides capital and strategic support to early-to-growth stage biotech, medical device, and digital health companies. It often operates in collaboration with the Changping Technology Park Development (CHG) and major industry partners to create a robust ecosystem for innovation. The fund's primary objective is to accelerate the commercialization of cutting-edge medical technologies and strengthen Beijing's position as a global hub for pharmaceutical R&D. By leveraging local government resources and industrial expertise, it serves as a critical bridge between scientific research and market-ready healthcare solutions.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Changping District Joint Innovative Fund.